Trials / Completed
CompletedNCT01027494
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora Distal to the Site of Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 318 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 6 Months – 4 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this observational study was to evaluate the effects of a topical fluoroquinolone (antibiotic) instilled into the otic (ear) canal to treat Acute Otitis Media through Tympanostomy Tubes (AOMT) on selected bacterial species on the skin near the ear, in the nose, and in the throat.
Detailed description
Pediatric patients with tympanostomy tubes were enrolled into one of two groups: 1) Treatment, i.e., patients with signs of otic infection, to be treated with CIPRODEX; or 2) Healthy, i.e., patients without signs of otic infection, to receive no treatment. Microbiological specimens were collected from four areas (ear canal, skin, nose, throat) during three study visits (Day 1, Day 8, and Day 42), and the specimens collected from the Healthy group served as a comparison (control) group for identifying fluoroquinolone (FQ) resistant bacterial strains.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension | Four drops in the outer ear canal of infected ear(s) while awake 2 times per day for 7 days |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2009-12-08
- Last updated
- 2013-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01027494. Inclusion in this directory is not an endorsement.